| Period Ending | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 |
|---|
|
Total Revenue
|
25,164,000
|
24,505,000
|
20,268,000
|
26,086,000
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
25,164,000
|
24,505,000
|
20,268,000
|
26,086,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 15,714,000 | 15,271,000 | 15,656,000 | 15,189,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 199,000 | 769,000 | 1,047,000 | 1,971,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
9,298,000
|
9,082,000
|
4,221,000
|
10,715,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 11,739,000 | 11,576,000 | 9,462,000 | 10,639,000 |
|
Interest Expense | 2,441,000 | 2,494,000 | 2,512,000 | 2,653,000 |
|
Income Before Tax | 9,298,000 | 9,082,000 | 6,950,000 | 7,986,000 |
|
Income Tax Expense | 2,802,000 | 2,553,000 | 1,258,000 | 2,278,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 6,496,000 | 6,529,000 | 5,692,000 | 5,708,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
6,496,000
|
6,529,000
|
5,692,000
|
5,708,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
6,101,000
|
6,131,000
|
5,321,000
|
5,346,000
|
|